Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.

NCT02710890 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Lacosamide

Sponsor

UCB BIOSCIENCES, Inc.